Abiopharma

🔍 Anderson Dennis L II (Executive)

Company: ARCBEST CORP /TX/ (ARCB)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Sold 3,347 shares of Common Stock, par value $0.01 per share at $134.87 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,750.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,103 shares of Common Stock, par value $0.01 per share at $135.63 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,647.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,950 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-08-11 | Code: G | equity_swap_involved: 0 | shares_owned_after: 12,697.00 | transaction_form_type: 4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.430 to $135.425, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.470 to $135.730, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.